Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Kaposi's sarcoma secondary prevention
Introduction
Overview
Overview
Secondary prevention of Kaposi’s sarcoma involves anti-retroviral therapy which can improve the CD4 T cell count.
Secondary Prevention
Secondary Prevention
Secondary prevention of Kaposi’s sarcoma involves anti-retroviral therapy which can improve the CD4 T cell count. Lower CD4 T cell counts (below 150 cells per microliter) are associated with worse prognosis and will result in worsening complications. Highly-active anti-retroviral therapy is important for prevention of worsening disease in patients who have Kaposi’s sarcoma.[1]
References
References
- ↑ Franceschi S, Maso LD, Rickenbach M, Polesel J, Hirschel B, Cavassini M; et al. (2008). “Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy”. Br J Cancer. 99 (5): 800–4. doi:10.1038/sj.bjc.6604520. PMC 2528138. PMID 18665172.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]